Informations générales (source: ClinicalTrials.gov)
Impact of a Decision-making Tool to Guide the Use of Physical Restraints in Intensive Care Unit Patients. A Multicentre Randomized Stepped-wedge Trial. (ARBORéa)
Interventional
N/A
University Hospital, Clermont-Ferrand (Voir sur ClinicalTrials)
mai 2022
février 2026
29 juin 2024
The use of physical restraints is common practice in Intensive Care Units (ICU). This
medically prescribed procedure requires full attention of medical and paramedical teams
for its implementation, monitoring and ending, as a major restriction of patients'
individual freedom. French highest authority for health has defined, for geriatrics and
psychiatric units, ten criteria of good practice for physical restraints' use. Routine
practice reports critically ill patients' safety as main reason of use. This decision,
often left to the sole discretion of nurses, varies according to their own representation
of this risk, and depends on several factors: seniority in ICU, nurse to patient ratio
and personal workload.
In order to reduce practices subjectivity and heterogeneity, we have developed a
decision-making tool for physical restraints implementation. This tool is based on
objective scales used on a daily basis concerning neurological status (Richmond
Agitation-Sedation Scale (RASS) and Confusion Assessment Method for the ICU (CAM-ICU)).
Disorientation or delirium can lead to severe incidents by promoting accidental removing
of important devices such as arterial of venous line, drains among others. However,
physical restraints are recognized as a major cause of delirium and agitation.
Critically ill patients require rigorous evaluation of organ dysfunctions necessitating
adequate invasive equipments, with associated risks of unexpected removal or alteration.
Such events could urge caregivers to use physical restraints. Based on recent literature,
about a third of ICU patients are restrained, and accidental deconditioning is mainly
observed within these particular patients.
In addition, three categories of patients have been defined according to the invasive
nature of their equipment and therefore according to the risk associated with an
unexpected withdrawal. Finally, presence of patient's family and their adherence to its
surveillance were also implemented into the tool. Main study objective is to jointly
investigate effectiveness and tolerance of a decision-making tool guiding physical
restraints use in ICU patients.
Etablissements
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
Assistance Publique-Hôpitaux de Marseille - La Timone - Marseille - France | Jeremy Bourenne | Contact (sur clinicalTrials) | |||
Centre Hospitalier de Montluçon - Montluçon - France | Contact (sur clinicalTrials) | ||||
Centre Hospitalier de Salon-de-Provence - Salon-de-Provence - France | Mélika BERRAHAL | Contact (sur clinicalTrials) | |||
Centre Hospitalier de Vichy - Vichy - France | Estelle MANTIN | Contact (sur clinicalTrials) | |||
Centre Hospitalier Universitaire - Hospices Civils de Lyon - Hôpital Edouard Herriot - Lyon - France | Florian DEGIVRY | Contact (sur clinicalTrials) | |||
Centre Hospitalier Universitaire de Nice - Nice - France | Nathalie REVEL | Contact (sur clinicalTrials) | |||
Centre Hospitalier Universitaire de Saint-Etienne - Saint-Étienne - France | Sandrine PIOT | Contact (sur clinicalTrials) | |||
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
Centre de Lutte Contre le Cancer Jean-Perrin - Clermont-Ferrand - France | Frédéric MOITRON | Contact (sur clinicalTrials) | |||
Centre Hospitalier d'Avignon - Avignon - France | Marie BONNEFOY | Contact (sur clinicalTrials) | |||
Centre Hospitalier du Puy en Velay - Le Puy-en-Velay - France | Isabelle ROURE | Contact (sur clinicalTrials) | |||
Centre Hospitalier Moulins-Yzeure - Moulins - France | Emilie DAVID | Contact (sur clinicalTrials) | |||
Centre Hospitalier Universitaire de Clermont-Ferrand - Clermont-Ferrand - France | Périne VIDAL | Contact (sur clinicalTrials) | |||
Centre Hospitalier Universitaire de Dijon - Dijon - France | Christina TERON | Contact (sur clinicalTrials) | |||
Centre Hospitalier Universitaire de Montpellier - Montpellier - France | Jeanne BOYER | Contact (sur clinicalTrials) | |||
Centre Hospitalier Universitaire de Strasbourg - Réa Chirurgicale - Strasbourg - France | Coralie RIEHL | Contact (sur clinicalTrials) | |||
Centre Hospitalier Universitaire de Strasbourg -MIR - Strasbourg - France | Sylvie L'HOTELLIER | Contact (sur clinicalTrials) | |||
CH de Saint Malo - Saint-Malo - France | Maureen BOTHOREL | Contact (sur clinicalTrials) | |||
CH Henri Mondor - Aurillac - France | Simon CLUSE | Contact (sur clinicalTrials) | |||
Hôpital de la Pitié Salpétrière - Paris - France | Claire FAZILLEAU | Contact (sur clinicalTrials) | |||
Hôpital Nord Franche-Comté - Belfort - France | Nahila HIMER | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- Patient, male or female, over 18 years of age, hospitalized in ICU for at least 48
hours.
- Consent to participate in the patient's study or authorization to carry out the
research collected from the designated trustworthy person (failing this, a family
member, or failing this, a close and stable relation with the person concerned)
according to the modalities described in Title II of the book of the First Public
Health Code. If no relative is present, the patient may be included on the advice of
the investigator (article L. 1111-6). A consent form for continuation of the study
and use of the data will then be signed by the patient if and when the patient is
again conscious and lucid, or if the patient is unable to express consent,
authorization to continue the research will be obtained from the designated trusted
person.
- Patient covered by a social security system.
- Patient, male or female, over 18 years of age, hospitalized in ICU for at least 48
hours.
- Consent to participate in the patient's study or authorization to carry out the
research collected from the designated trustworthy person (failing this, a family
member, or failing this, a close and stable relation with the person concerned)
according to the modalities described in Title II of the book of the First Public
Health Code. If no relative is present, the patient may be included on the advice of
the investigator (article L. 1111-6). A consent form for continuation of the study
and use of the data will then be signed by the patient if and when the patient is
again conscious and lucid, or if the patient is unable to express consent,
authorization to continue the research will be obtained from the designated trusted
person.
- Patient covered by a social security system.
- Predictable and uninterrupted maintenance of deep sedation throughout the duration
of the stay, due to the seriousness of the lesions, from the moment the patient is
admitted to the intensive care unit.
- Lack of predictable remission of a severe coma present on admission to intensive
care.
- Refusal to participate by the patient, or by the trusted person contacted by
default.
- Patient with DNR (do not resuscitate) orders.
- Patient under legal protection.
- Patient already included in the protocol during another stay in resuscitation